Clinical Trials Directory

Trials / Conditions / Uterine Neoplasms

Uterine Neoplasms

44 registered clinical trials studyying Uterine Neoplasms6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingProspective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometria
NCT07382505
Asan Medical Center
Active Not RecruitingA Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
NCT07038369
Atavistik Bio, IncPhase 1
CompletedAnterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies
NCT07046949
Yuri Semenyuk Rivne Regional Clinical HospitalN/A
RecruitingUltrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study
NCT06953076
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RecruitingRetrospective Study of Brachytherapy
NCT05242861
Zhejiang Cancer Hospital
CompletedEarly Feasibility Study of the "Easy Light" Fluorecence Imaging System
NCT05004623
Professor Fernando Figueira Integral Medicine InstituteN/A
RecruitingEvaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms
NCT06774482
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Active Not RecruitingBasket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
NCT04579380
Seagen, a wholly owned subsidiary of PfizerPhase 2
CompletedSelf-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
NCT04679675
Kaiser PermanenteN/A
CompletedImpact of the COVID-19 Pandemic in Gynecological Oncology
NCT04351139
Hospices Civils de Lyon
UnknownAn In-vitro Real-time System Based on Tissue Smears to Identify Malignancy During Hysteroscopic Procedure
NCT03971032
Hillel Yaffe Medical CenterN/A
UnknownERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy.
NCT04063072
Ospedale Regina Montis RegalisN/A
RecruitingResearch Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preve
NCT04061967
Karolinska InstitutetN/A
UnknownDurvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer
NCT03951415
Leiden University Medical CenterPhase 2
CompletedSentinel Node Mapping in Women With Cervical and Endometrial Cancer
NCT02825355
University of Southern Denmark
UnknownSentinel Node Mapping in Women With Endometrial and Cervical Cancer
NCT02820506
University of Southern DenmarkN/A
CompletedMRI and Metabolomics Biomarkers for Uterine Malignancy
NCT02528864
Chang Gung Memorial Hospital
CompletedBiobehavioral Intervention in Gynecologic Oncology Patients
NCT02454036
Rachel MillerPhase 2
CompletedGuided Imagery in the Perioperative Period in Gynecologic Oncology Patients
NCT02444195
University of MichiganN/A
CompletedKnowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients
NCT02374411
Edward Hospital
Active Not RecruitingRT for Cervical Adenocarcinoma/adenosquamous Carcinoma
NCT06741046
Peking Union Medical College Hospital
TerminatedEvaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology
NCT01969396
Cook Group IncorporatedN/A
TerminatedObservational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intraute
NCT01998854
Gynesonics
UnknownSentinel Node Biopsy in Endometrial Cancer
NCT01564264
Hamilton Health Sciences CorporationN/A
CompletedA Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
NCT01654458
Women's College HospitalN/A
RecruitingAnalysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
NCT03624712
University Hospital Tuebingen
TerminatedChemoFx® PRO - A Post-Market Data Collection Study
NCT00669422
Precision Therapeutics
CompletedA Trial for Patients With Advanced/Recurrent Endometrial Cancer
NCT00377520
Eli Lilly and CompanyPhase 2
CompletedComparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Ag
NCT00361036
Worthington-Kirsch, Robert L., M.D.Phase 1
CompletedA Trial for Patients With Gestational Trophoblastic Disease
NCT00190918
Eli Lilly and CompanyPhase 2
CompletedA Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Ut
NCT00628901
Boston Scientific CorporationPhase 4
CompletedA Trial for Patients With Advanced/Recurrent Cervical Cancer
NCT00190983
Eli Lilly and CompanyPhase 2
CompletedAcupuncture for Women's Health Conditions
NCT00090389
National Center for Complementary and Integrative Health (NCCIH)Phase 1
CompletedEfficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
NCT00231855
Montefiore Medical CenterPhase 2
CompletedCombidex USPIO - Ultra-small Superparamagnetic Iron Oxide
NCT00188695
University Health Network, TorontoPhase 1 / Phase 2
CompletedIntensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)
NCT00188578
University Health Network, TorontoPhase 1 / Phase 2
CompletedMagnetic Resonance Imaging Guided Gynecologic Brachytherapy
NCT00112307
Brigham and Women's HospitalN/A
TerminatedPatients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer
NCT00782041
SanofiPhase 2
CompletedPhase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma
NCT00050440
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2
CompletedPre-Clinical Models in Gynecological Tumors A Tissue Repository
NCT00250783
University of New Mexico
CompletedSelf-Hypnotic Relaxation Therapy During Invasive Procedures
NCT00087841
National Center for Complementary and Integrative Health (NCCIH)Phase 2
TerminatedMalignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy
NCT00505492
M.D. Anderson Cancer CenterPhase 2
CompletedEmmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids
NCT00100191
ZonMw: The Netherlands Organisation for Health Research and DevelopmentPhase 3
WithdrawnColony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis
NCT00250770
University of New Mexico